Loading
Latest filing published 11 Apr 2017 for Immunotec Inc. (formerly Magistral Biotech Inc.), €4,249.
Charles Lee Orr appears in our data through filings on Immunotec Inc. (formerly Magistral Biotech Inc.) shares, published by SEDI. Between 2 February 2016 and 10 April 2017, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 11 April 2017: an option exercise of €4,249, in Immunotec Inc. (formerly Magistral Biotech Inc.). These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations